PREGNANTS working group releases results of large study
The PREGNANTS working group, (PREGNancy in women with ANTiphospholipid Syndrome), has just released the results of a large study. The trial investigated 750 pregnancies in women with primary APS looking at the outcomes associated with the different types of antibodies - Lupus anticoagulant (LA), anticardiolipin (aCL) and the anti-beta-glycoprotein1 (ab2GPI). They found that aCL is the most common antiphospholipid antibody present, but ab2GPI is the one associated with the low est livebirth rate and highest incidence of pre-eclampsia, low weight babies and stillbirth, compared to presence of aCL or LA alone. This pivotal study will help guide research in the future, thanks to all those women who took part. http://www.ajog.org/article/S0002-9378(17)30148-5/fulltext …